类有机物
精密医学
胰腺导管腺癌
胰腺癌
医学
癌症
腺癌
肿瘤科
内科学
病理
生物
神经科学
作者
Yuqing Zhang,Courtney W. Houchen,Min Li
标识
DOI:10.1158/1078-0432.ccr-22-1083
摘要
Summary The patient-derived organoids (PDO) platform recapitulates the phenotype, genotype, and molecular characteristics of primary tumors. High-throughput drug screening in terms of pharmacotyping using standard-of-care chemotherapy agents in the PDO platform has shown promising sensitivities to guide precision medicine for individual patients with pancreatic ductal adenocarcinoma (PDAC) within a clinically relevant time frame. See related article by Seppälä et al., p. 3296
科研通智能强力驱动
Strongly Powered by AbleSci AI